Based on the AmerisourceBergen Corporation stock forecast from 0 analysts, the average analyst target price for AmerisourceBergen Corporation is not available over the next 12 months. AmerisourceBergen Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AmerisourceBergen Corporation is Slightly Bearish, which is based on 6 positive signals and 8 negative signals. At the last closing, AmerisourceBergen Corporation’s stock price was EUR 232.30. AmerisourceBergen Corporation’s stock price has changed by +2.09% over the past week, +8.25% over the past month and +28.81% over the last year.
No recent analyst target price found for AmerisourceBergen Corporation
No recent average analyst rating found for AmerisourceBergen Corporation
Company Overview AmerisourceBergen Corporation
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Read Less
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health system...Read More
Frequently Asked Questions About AmerisourceBergen Corporation (ABG:F) Stock
Stock Target Advisor's fundamental analysis for AmerisourceBergen Corporation's stock is Slightly Bearish.
ABG:F stock's dividend yield is 0.91%.
Our analysis grades ABG:F stock's dividend yield at F. This means that ABG:F stock's dividend yield is above 17% of the stocks in the Medical Distribution sector in the F exchange.
Based on this ABG:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on ABG:F's stock to indicate what its average analyst target is.
ABG:F stock's Price/Earning ratio is 32.54.
Our analysis grades ABG:F stock's Price / Earning ratio at F. This means that ABG:F stock's Price/Earning ratio is above 74% of the stocks in the Medical Distribution sector in the F exchange.
Based on this ABG:F may be a overvalued for its sector.
The last closing price of ABG:F's stock was EUR 232.30.
The most recent market capitalization for ABG:F is EUR 45.78B.
Unfortunately we do not have enough analyst data on ABG:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains AmerisourceBergen Corporation's stock.
As per our most recent records AmerisourceBergen Corporation has 46,000 Employees.
AmerisourceBergen Corporation's registered address is 1 West First Avenue, Conshohocken, PA, United States, 19428-1800.
You can get more information about it from AmerisourceBergen Corporation's website at https://www.cencora.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About AmerisourceBergen Corporation (ABG:F) Stock
Stock Target Advisor's fundamental analysis for AmerisourceBergen Corporation's stock is Slightly Bearish.
ABG:F stock's dividend yield is 0.91%.
Our analysis grades ABG:F stock's dividend yield at F. This means that ABG:F stock's dividend yield is above 17% of the stocks in the Medical Distribution sector in the F exchange.
Based on this ABG:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on ABG:F's stock to indicate what its average analyst target is.
ABG:F stock's Price/Earning ratio is 32.54.
Our analysis grades ABG:F stock's Price / Earning ratio at F. This means that ABG:F stock's Price/Earning ratio is above 74% of the stocks in the Medical Distribution sector in the F exchange.
Based on this ABG:F may be a overvalued for its sector.
The last closing price of ABG:F's stock was EUR 232.30.
The most recent market capitalization for ABG:F is EUR 45.78B.
Unfortunately we do not have enough analyst data on ABG:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains AmerisourceBergen Corporation's stock.
As per our most recent records AmerisourceBergen Corporation has 46,000 Employees.
AmerisourceBergen Corporation's registered address is 1 West First Avenue, Conshohocken, PA, United States, 19428-1800.
You can get more information about it from AmerisourceBergen Corporation's website at https://www.cencora.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ABG:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
